Literature DB >> 23729733

Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A.

Dean Hammond1, Kang Zeng, Antonio Espert, Ricardo Nunes Bastos, Ryan D Baron, Ulrike Gruneberg, Francis A Barr.   

Abstract

Mutations in the PPP6C catalytic subunit of protein phosphatase 6 (PP6) are drivers for the development of melanoma. Here, we analyse a panel of melanoma-associated mutations in PPP6C and find that these generally compromise assembly of the PP6 holoenzyme and catalytic activity towards a model substrate. Detailed analysis of one mutant, PPP6C-H114Y, in both primary melanoma and engineered cell lines reveals it is destabilized and undergoes increased proteasome-mediated turnover. Global analysis of phosphatase substrates by mass spectrometry identifies the oncogenic kinase Aurora-A as the major PP6 substrate that is dysregulated under these conditions. Accordingly, cells lacking PPP6C or carrying the PPP6C-H114Y allele have elevated Aurora-A kinase activity and display chromosome instability with associated Aurora-A-dependent micronucleation. Chromosomes mis-segregated to these micronuclei are preferentially stained by the DNA damage marker γ-H2AX, suggesting that loss of PPP6C promotes both chromosome instability and DNA damage. These findings support the view that formation of micronuclei rather than chromosome instability alone explains how loss of PPP6C, and more generally mitotic spindle and centrosome defects, can act as drivers for genome instability in melanoma and other cancers.

Entities:  

Keywords:  Aurora-A; Chromothripsis; Protein phosphatase 6

Mesh:

Substances:

Year:  2013        PMID: 23729733     DOI: 10.1242/jcs.128397

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  36 in total

1.  Adaptation of HepG2 cells to a steady-state reduction in the content of protein phosphatase 6 (PP6) catalytic subunit.

Authors:  Joan M Boylan; Arthur R Salomon; Umadevi Tantravahi; Philip A Gruppuso
Journal:  Exp Cell Res       Date:  2015-05-18       Impact factor: 3.905

2.  Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma.

Authors:  Jordan Wengrod; Ding Wang; Sarah Weiss; Hua Zhong; Iman Osman; Lawrence B Gardner
Journal:  Sci Signal       Date:  2015-03-10       Impact factor: 8.192

3.  Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Authors:  Paolo A Ascierto; Antonio M Grimaldi; Ana Carrizosa Anderson; Carlo Bifulco; Alistair Cochran; Claus Garbe; Alexander M Eggermont; Mark Faries; Soldano Ferrone; Jeffrey E Gershenwald; Thomas F Gajewski; Ruth Halaban; F Stephen Hodi; Richard Kefford; John M Kirkwood; James Larkin; Sancy Leachman; Michele Maio; Richard Marais; Giuseppe Masucci; Ignacio Melero; Giuseppe Palmieri; Igor Puzanov; Antoni Ribas; Yvonne Saenger; Bastian Schilling; Barbara Seliger; David Stroncek; Ryan Sullivan; Alessandro Testori; Ena Wang; Gennaro Ciliberto; Nicola Mozzillo; Francesco M Marincola; Magdalena Thurin
Journal:  J Transl Med       Date:  2014-10-28       Impact factor: 5.531

4.  PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition.

Authors:  Heidi L Gold; Jordan Wengrod; Eleazar Vega-Saenz de Miera; Ding Wang; Nathaniel Fleming; Lisa Sikkema; Tomas Kirchhoff; Tsivia Hochman; Judith D Goldberg; Iman Osman; Lawrence B Gardner
Journal:  Mol Cancer Res       Date:  2013-12-12       Impact factor: 5.852

5.  Quantitative phosphoproteomics reveals new roles for the protein phosphatase PP6 in mitotic cells.

Authors:  Scott F Rusin; Kate A Schlosser; Mark E Adamo; Arminja N Kettenbach
Journal:  Sci Signal       Date:  2015-10-13       Impact factor: 8.192

6.  A water-mediated allosteric network governs activation of Aurora kinase A.

Authors:  Soreen Cyphers; Emily F Ruff; Julie M Behr; John D Chodera; Nicholas M Levinson
Journal:  Nat Chem Biol       Date:  2017-02-06       Impact factor: 15.040

7.  Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Authors:  Ximena Bonilla; Laurent Parmentier; Bryan King; Fedor Bezrukov; Gürkan Kaya; Vincent Zoete; Vladimir B Seplyarskiy; Hayley J Sharpe; Thomas McKee; Audrey Letourneau; Pascale G Ribaux; Konstantin Popadin; Nicole Basset-Seguin; Rouaa Ben Chaabene; Federico A Santoni; Maria A Andrianova; Michel Guipponi; Marco Garieri; Carole Verdan; Kerstin Grosdemange; Olga Sumara; Martin Eilers; Iannis Aifantis; Olivier Michielin; Frederic J de Sauvage; Stylianos E Antonarakis; Sergey I Nikolaev
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

8.  Evidence toward a dual phosphatase mechanism that restricts Aurora A (Thr-295) phosphorylation during the early embryonic cell cycle.

Authors:  Qing Kang; Jeyaraman Srividhya; Joseph Ipe; Joseph R Pomerening
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

9.  CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

Authors:  Norman Ertych; Ailine Stolz; Oliver Valerius; Gerhard H Braus; Holger Bastians
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

10.  Protein phosphatase 6 is a key factor regulating spermatogenesis.

Authors:  Wen-Long Lei; Feng Han; Meng-Wen Hu; Qiu-Xia Liang; Tie-Gang Meng; Qian Zhou; Ying-Chun Ouyang; Yi Hou; Heide Schatten; Zhen-Bo Wang; Qing-Yuan Sun
Journal:  Cell Death Differ       Date:  2019-12-09       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.